NCT03899558View on ClinicalTrials.gov

The Role of HNHF to Improve Clinical Outcomes Following Severe AECOPD

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 17, 2019

Primary Completion Date

March 24, 2021

Study Completion Date

March 24, 2021

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DEVICE

Humidified nasal high-flow device

Humidified nasal high-flow device which delivers warmed, humidified air at flow rates of up to 60 litres per minute via a nasal cannula interface. Intended delivery at 30 L/min at 37 degrees Celsius, if tolerated.

Trial Locations (1)

SE1 7EH

Guy's and St Thomas' NHS Foundation Trust, London

All Listed Sponsors
lead

Guy's and St Thomas' NHS Foundation Trust

OTHER

NCT03899558 - The Role of HNHF to Improve Clinical Outcomes Following Severe AECOPD | Biotech Hunter | Biotech Hunter